Pfizer
Pfizer Inc. is a premier global biopharmaceutical corporation headquartered in New York City, dedicated to discovering and developing innovative healthcare solutions. The company focuses on discovering, developing, manufacturing, and marketing prescription medicines, vaccines, and advanced biologic therapies across multiple therapeutic areas. Its expansive pharmaceutical portfolio includes landmark treatments in oncology, immunology, cardiology, neurology, rare diseases, and infectious disease prevention. Pfizer routinely invests billions of dollars into cutting-edge research and clinical trial programs to address complex medical challenges and unfulfilled patient needs around the world. As global demographics shift toward aging populations, the enterprise continuously expands its therapeutic interventions targeting age-related chronic conditions and degenerative diseases. The corporation actively collaborates with global healthcare providers, research institutions, and governmental bodies to expand patient access to critical life-saving medications. Through pioneering mRNA technology, innovative science, and global digital health solutions, Pfizer remains deeply committed to advancing modern medicine and improving human health outcomes worldwide.
82 of the funds FundTelligence covers report a position in Pfizer.
- Legal name
- Pfizer Inc.
- Sector
- Health Care
- Country
- United States
- Funds holding it
- 82
Funds holding Pfizer
- Investerum Equity Value — Investerum · 4.31 % (full portfolio disclosed, June 2026)
- DWS Invest CROCI Sectors Plus — DWS · 3.11 % (full portfolio disclosed, June 2026)
- Storebrand Global High Dividend Low Volatility — Storebrand · 2.98 % (full portfolio disclosed, October 2026)
- Sparinvest Ethical Global Value — Sparinvest · 2.43 % (full portfolio disclosed, September 2026)
- DWS Invest CROCI US — DWS · 2.39 % (full portfolio disclosed, June 2026)
- Sparinvest Global Value — Sparinvest · 2.17 % (full portfolio disclosed, September 2026)
- Schroder ISF Global Dividend Maximiser — Schroders · 2.07 % (full portfolio disclosed, June 2026)
- Schroder ISF Global Equity Yield — Schroders · 2.02 % (full portfolio disclosed, June 2026)
Showing the 8 largest of 82 funds holding it.